| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-18 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-15 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-13 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-13 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-12 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-11 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-11 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-09 |